Eballena, Zaye Seff .

HRN: 23-47-03  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2023
CEFUROXIME 750MG (VIAL)
09/07/2023
09/14/2023
IV
230mg
Q8
PCAP C
Waiting Final Action 
09/08/2023
CEFTRIAXONE 1G (VIAL)
09/08/2023
09/14/2023
IV
690mg
OD
PCAP, Severe
Waiting Final Action 
09/10/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
09/10/2023
09/14/2023
PER OGT
2ml
OD
PCAP C
Waiting Final Action 
09/11/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/11/2023
09/17/2023
IV
180mg
Q6
PCAP D
Waiting Final Action 
09/11/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/11/2023
09/17/2023
IV
80mg
Q8h
AGE
Waiting Final Action 
09/19/2023
CIPROFLOXACIN 500MG (TAB)
09/19/2023
09/25/2023
ORAL
100mg Pptab
Q12
Pcap C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: